BNTC
NASD Benitec Biopharma Inc$9.23 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.23, $0.76 below the day’s high of $9.99
- YTD change
- -31.48%
- vs 20-day SMA
- -15.33%
- vs 200-day SMA
- -22.47%
Price ranges
Price & Performance
-1.76 (-16.01%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.0% away from all-time highs of $931.60
- BNTC is down 31% since the beginning of the year
- BNTC is down 33% over the past 12 months
- BNTC is down 26% over the past 1 month
- 8% of all BNTC investors are betting against BNTC
BNTC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -32.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.47
- Last 5 days
- -3.75%
- vs 8-day SMA
- -4.59%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
